[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@COR2EDMedEd](/creator/twitter/COR2EDMedEd) "HR+/HER2 metastatic breast cancer can be complex to treat particularly once endocrine resistance develops. In this case-based video Dr Barbara Pistilli discusses the journey of a pretreated patient with HR+/HER2 (IHC 0) mBC who developed endocrine resistance. She explores: ADCs as effective manageable alternatives to ChT Mechanism of action & available options Strategies for managing AEs Watch the case study on YouTube here: #BreastCancer #MedEd #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca" [X Link](https://x.com/COR2EDMedEd/status/1980626651860898173) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-21T13:26Z 1004 followers, XX engagements "Just released Gastric & gastroesophageal cancer update from ESMO25 📺 Dr @LizzySmyth1 shares her gastric & GE cancer highlights & reviews the latest data from MATTERHORN trial This independent programme is supported by COR2ED" [X Link](https://x.com/COR2EDMedEd/status/1980936719882166537) [@COR2EDMedEd](/creator/x/COR2EDMedEd) 2025-10-22T09:58Z 1005 followers, 61.3K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@COR2EDMedEd
"HR+/HER2 metastatic breast cancer can be complex to treat particularly once endocrine resistance develops. In this case-based video Dr Barbara Pistilli discusses the journey of a pretreated patient with HR+/HER2 (IHC 0) mBC who developed endocrine resistance. She explores: ADCs as effective manageable alternatives to ChT Mechanism of action & available options Strategies for managing AEs Watch the case study on YouTube here: #BreastCancer #MedEd #Oncology This educational programme is supported by an Independent Educational Grant from AstraZeneca"
X Link @COR2EDMedEd 2025-10-21T13:26Z 1004 followers, XX engagements
"Just released Gastric & gastroesophageal cancer update from ESMO25 📺 Dr @LizzySmyth1 shares her gastric & GE cancer highlights & reviews the latest data from MATTERHORN trial This independent programme is supported by COR2ED"
X Link @COR2EDMedEd 2025-10-22T09:58Z 1005 followers, 61.3K engagements
/creator/twitter::719588640171696129/posts